Inclusion Criteria:  Age ≥18 Confirmed fully resected Stage IIIb-IV cutaneous melanoma; including patients treated neoadjuvantly within three months prior to resection.  Exclusion Criteria:  • Treatment plan inconsistent with the standard of care systemic adjuvant therapies 4.0 Study Design